Results 11 to 20 of about 25,315 (305)

Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses. [PDF]

PLoS ONE, 2015
Apolipoprotein E (ApoE), an exchangeable apolipoprotein, is necessary for production of infectious Hepatitis C virus (HCV) particles. However, ApoE is not the only liver-expressed apolipoprotein and the role of other apolipoproteins for production of ...
Kathrin Hueging, Romy Weller, Mandy Doepke, Gabrielle Vieyres, Daniel Todt, Benno Wölk, Florian W R Vondran, Robert Geffers, Chris Lauber, Lars Kaderali, François Penin, Thomas Pietschmann   +11 more
doaj   +2 more sources

Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.

PLoS Pathogens, 2014
Apolipoprotein B (ApoB) and ApoE have been shown to participate in the particle formation and the tissue tropism of hepatitis C virus (HCV), but their precise roles remain uncertain.
Takasuke Fukuhara, Masami Wada, Shota Nakamura, Chikako Ono, Mai Shiokawa, Satomi Yamamoto, Takashi Motomura, Toru Okamoto, Daisuke Okuzaki, Masahiro Yamamoto, Izumu Saito, Takaji Wakita, Kazuhiko Koike, Yoshiharu Matsuura   +13 more
doaj   +2 more sources

Relationship between depression and apolipoproteins A and B: a case-control study [PDF]

Clinics, 2011
OBJECTIVE: To investigate the relation between major depressive disorder and metabolic risk factors of coronary heart disease. INTRODUCTION: Little evidence is available indicating a relationship between major depressive disorder and metabolic risk ...
Masoumeh Sadeghi, Hamidreza Roohafza, Hamid Afshar, Fereshteh Rajabi, Mohamadarash Ramzani, Hasan Shemirani, Nizal Sarafzadeghan   +6 more
doaj   +2 more sources

Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial [PDF]

, 2023
Background: The STAtins Reduce Thrombophilia trial showed that, in patients with prior venous thrombosis, rosuvastatin decreased various coagulation factor levels.
van Vlijmen, Bart J.M., Cannegieter, S.C., Frank W. Leebeek, Biedermann, J.S., Bart J.M. van Vlijmen, van der Meer, Felix J., Nienke van Rein, Camilleri, E., Kruip, M.J.H.A., Eleonora Camilleri, Lijfering, W.M., Suzanne C. Cannegieter, Rein, N. van, Cobbaert, Christa M., Willem M. Lijfering, Meer, F.J. van der, Kruip, Marieke J.H.A., Felix J. van der Meer, Joseph S. Biedermann, Leebeek, Frank W.; id_orcid, van Rein, Nienke, Vlijmen, B.J.M. van, Biedermann, Joseph S., Cannegieter, Suzanne C., Christa M. Cobbaert, Leebeek, Frank W., Leebeek, F.W., Lijfering, Willem M., Marieke J.H.A. Kruip, Camilleri, Eleonora, Cobbaert, C.M.   +30 more
core   +1 more source

Levels of apolipoproteins as risk factors for coronary artery disease Níveis de apolipoproteínas como fatores de risco para doença arterial coronariana

Jornal Vascular Brasileiro, 2011
INTRODUCTION: The Saudi population is renowned for their unhealthy diet and physical inactivity. OBJECTIVE:To investigate apolipoproteins B (apo B), A-I (apo A-I) and B/A-I as risk factors that might be associated with increased incidence of the coronary
Mohmed Ashmaig, Khalifa Ashmeik, Atif Ahmed, Samia Sobki, Muheeb Abdulla   +4 more
doaj   +1 more source

Diagnostic and pathogenetic significance of apolipoprotein disorders in patients with alcoholic fatty liver [PDF]

Vojnosanitetski Pregled, 2017
Background/Aim. Alcohol is the most common cause of fatty liver. Alcohol metabolism takes place in the liver by alcohol dehydrogenase, to toxic acetaldehyde, with fatty acids accumulation in the liver as a consequence.
Mladenović Bojan, Brzački Vesna, Benedeto-Stojanov Daniela, Mladenović Nikola   +3 more
doaj   +1 more source

Dabigatran and apolipoprotein B [PDF]

Heart, 2015
Dabigatran is the first of a series of new direct acting oral anticoagulants that was clinically introduced for the prevention of ischaemic stroke in patients with atrial fibrillation (AF). In the randomized evaluation of long-term anticoagulation therapy (RE-LY) study, dabigatran was shown to be superior or non-inferior to warfarin in preventing ...
openaire   +2 more sources

New in vitro effects of clopidogrel on platelets in hyperlipidemic and healthy subjects

Turkish Journal of Hematology, 2010
Objective: We aimed to detect novel in vitro effects of clopidogrel on platelets by assessment of the following parameters: malondialdehyde, glutathione, nitrite, aggregation response, and expressions of P-selectin, fibrinogen, apolipoprotein A1 ...
Derya Özsavcı, Azize Şener, Rabia Oba, Gülderen Yanıkkaya Demirel, Fikriye Uras, Turay Kevser Yardımcı   +5 more
doaj   +3 more sources

Dynamic interfacial properties of human apolipoproteins A-IV and B-17 at the air/water and oil/water interface

Journal of Lipid Research, 2000
Viscoelastic behavior of proteins at interfaces is a critical determinant of their ability to stabilize emulsions. We therefore used air bubble surfactometry and drop volume tensiometry to examine the dynamic interfacial properties of two plasma ...
Richard B. Weinberg, Victoria R. Cook, Jeanine A. DeLozier, Gregory S. Shelness   +3 more
doaj   +1 more source

Degradation of human apolipoprotein B‐100 by apolipoprotein(a)

FEBS Letters, 1993
Human plasma low density lipoproteine (LDL) contain a very high molecular weight protein termed apoB‐100 (M r = 550,000). In many samples of LDL, minor components designated as apoB‐74 (M r = 407,000) and apoB‐26 (M r = 145,000) are present. It has been shown that they can arise as a result of proteolytic degradation of apoB‐100.
Chulkova, T.M., Tertov, V.V.
openaire   +2 more sources